Health Systems for Tuberculosis (HS4TB)

Health Systems for Tuberculosis (HS4TB)

HS4TB Fact Sheets

Overview

​​The USAID Health Systems for Tuberculosis (HS4TB) project seeks to transform the way leaders and managers understand and work toward TB control and elimination. HS4TB builds on efforts to increase investments from the public and private sectors to end the TB epidemic while building local commitment and capacity to put the world on track to ending TB by 2030 and providing lifesaving treatment for 45 million people between 2023 and 2027. 

HS4TB focuses on selected countries within USAID’s priority countries with high burdens of TB, where it aligns with local communities and partners to deliver performance-based results toward global targets. The project works in Bangladesh, Ethiopia, India, and Kenya, where we help countries increase domestic financing, use key TB resources more efficiently, build in-country technical and managerial competence and leadership, and support policy formation and dissemination. HS4TB also prepares local organizations to transition into the role of primary technical assistance providers and recipients of direct donor support and engage marginalized groups, including women and youth, in co-creating activities with national TB programs, professional associations, civil society, and other stakeholders.

To assist governments and TB leaders and managers in achieving and sustaining transformation, we partner with public financing expert Nathan Associates; women-owned small business Open Development, LLC; and an array of local partners.

On December 3, 2024, MSH-led USAID’s Health Systems for Tuberculosis (HS4TB) hosted a webinar to debate the role of government-led contracting of the private health sector in delivering select health services in low- and middle-income countries. The discussion, part of USAID’s Health System Strengthening Series, featured public health leaders sharing insights from Bangladesh, India, and other high tuberculosis burden countries where such contracting mechanisms are being established or implemented.

Accelerating the End of TB: Field Research from Management Sciences for Health—2008-2024

Our volume of more than 120 peer-reviewed journal articles highlights MSH’s long-term commitment to ending the TB epidemic. Authored or co-authored by MSH technical experts for close to 20 years, these articles are important contributions to the evidence base of what works in the fight against TB, including systems strengthening innovations that improve access to both established and novel TB medicines, ensure safety and quality, and promote effective detection and case management.

TB FSI: Creating a Picture of Viable Funding for TB

At the United Nations High-Level Meeting on Tuberculosis in 2023, the world’s highest-burden countries committed to increasing domestic funding for TB prevention, treatment, and eradication efforts. In collaboration with partner Open Development LLC, the HS4TB project created a self-assessment tool—the TB Financial Sustainability Index (TB FSI)—to assist countries in identifying challenges and opportunities for sustainably financing their TB elimination efforts.

Join MSH at the Union World Conference on Lung Health 2024

Focused on our approaches in Ethiopia, Afghanistan, and Indonesia, our MSH delegates will discuss tuberculosis (TB) prevention and treatment in post-conflict environments, engagement of local organizations to ensure the sustainability of TB programs, and the development of public-private partnerships to elevate TB care delivery.

Dr. Kamiar Khajavi, Senior Technical Director, Universal Health Coverage at MSH and Executive Director at Joint Learning Network for UHC, Network Manager
Kamiar Khajavi

Project Director, HS4TB 

Project Contact

Dr. Kamiar Khajavi, Senior Technical Director; Project Director, HS4TB, works with our colleagues and external parties on all aspects of health systems financing and policy. In the seven years before joining us, Dr. Khajavi served at USAID as an advisor in the Bureau for Global Health reporting to the Assistant Administrator. His portfolio included health finance, global health policy, and management, workforce and compliance issues. Before USAID, Dr. Khajavi worked as a consultant in the Washington DC office of McKinsey & Co., where he served private and public sector clients. In the more distant past, he was an attending physician (internal medicine) at New York Presbyterian Hospital and on the faculty of the Weil Cornell Medical College. Dr. Khajavi has also worked in financial law and investment banking. He holds a JD and MPH from Columbia University and an MD from the University of Pennsylvania.